Optimizing therapy of seizures in children and adolescents with developmental disabilities
- PMID: 17190924
- DOI: 10.1212/wnl.67.12_suppl_4.s52
Optimizing therapy of seizures in children and adolescents with developmental disabilities
Abstract
Children and adolescents with intellectual and developmental disabilities and epilepsy are a unique patient population that offers significant challenges. They are more likely to suffer lifelong intractable epilepsy with multiple seizure types than other patients with epilepsy. In addition, these patients often cannot clearly express their complaints about antiepileptic drug (AED) side effects, and the caregiver's role becomes all-important as an advocate for the patient. Finally, behavioral and psychiatric comorbidities are common and need to be considered when choosing an AED in this patient population. Our society will be judged by how we care for the most unfortunate among us.
Similar articles
-
Behavioral disorders in Japanese epileptic children.Folia Psychiatr Neurol Jpn. 1983;37(3):259-65. doi: 10.1111/j.1440-1819.1983.tb00327.x. Folia Psychiatr Neurol Jpn. 1983. PMID: 6202607
-
Significant anticonvulsant side-effects in children and adolescents.J Clin Neurosci. 2000 May;7(3):213-6. doi: 10.1054/jocn.1999.0190. J Clin Neurosci. 2000. PMID: 10833618
-
Delivery of epilepsy care to adults with intellectual and developmental disabilities.Neurology. 2015 Oct 27;85(17):1512-21. doi: 10.1212/WNL.0000000000002060. Epub 2015 Sep 30. Neurology. 2015. PMID: 26423430 Free PMC article. Review.
-
Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities.Seizure. 2002 Jan;11(1):47-50. doi: 10.1053/seiz.2001.0571. Seizure. 2002. PMID: 11888260
-
Treatment of seizures and epilepsy in children and adolescents.Neurology. 1998 Nov;51(5 Suppl 4):S8-14. doi: 10.1212/wnl.51.5_suppl_4.s8. Neurology. 1998. PMID: 9818918 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical